Pulse Brain · Growing Health Evidence Index
Peer-reviewed

STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance

Tianye Li, Weijiang Zhang, Mengke Niu, Yuze Wu, Xinyue Deng, Jianwei Zhou

Frontiers in Immunology · 2024

Read source ↗ All evidence

Summary

This study highlights the pivotal role of the STING pathway and the potential of MSA-2 in reshaping the immune microenvironment in cervical cancer. Combining MSA-2 with immune checkpoint inhibitors presents a transformative approach, holding promise for improved prognosis. Further investigations are warranted to explore the broader immune landscape and potential long-term effects of MSA-2 in cervical cancer treatment.

Source type
Peer-reviewed study
DOI
10.3389/fimmu.2024.1342647
Catalogue ID
SNmoht1u9l-n0sp5m
Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.

How does this finding apply in a UK context?→What are the most cited records on this topic?→